Efficacy of select antivirals against Cryptosporidium parvum in vitro
1Division of Biology, Kansas State University, Manhattan 66506, USA. kemew@ksu.edu
Abstract:
Cryptosporidium parvum is an intestinal pathogen associated with diarrheal disease in both humans and animals. Currently, no effective therapy exists to eliminate the parasite in the absence of a healthy, intact immune system. We used an in situ, enzyme-linked immunosorbent assay (ELISA) as a primary screen to examine the effects of 13 antivirals on the development of C. parvum in human ileocecal adenocarcinoma (HCT-8) cells in vitro. Six of the compounds displayed some efficacy, and dose-response curves and toxicity assays were generated for each of the six compounds. All six were nucleoside analogs, and five of the six were structurally related. These results suggest one potential strategy for therapeutic intervention of C. parvum may be the use and development of certain types of nucleoside analogs.
Insights
No effective treatments exist for Cryptosporidium parvum infections. This study screened antiviral nucleoside analogs, finding six effective compounds that warrant further development for treating this intestinal parasite.
Area of Science:
- Parasitology
- Infectious Diseases
- Drug Discovery
Background:
- Cryptosporidium parvum is a significant intestinal pathogen causing diarrheal disease in humans and animals.
- Current therapeutic options are limited, especially for immunocompromised individuals.
Purpose of the Study:
- To screen antiviral compounds for efficacy against Cryptosporidium parvum development in vitro.
- To identify potential therapeutic strategies for cryptosporidiosis.
Main Methods:
- An in situ enzyme-linked immunosorbent assay (ELISA) was employed for primary screening.
- Thirteen antiviral compounds were tested against C. parvum in human ileocecal adenocarcinoma (HCT-8) cells.
- Dose-response and toxicity assays were performed on effective compounds.
Main Results:
- Six of the 13 tested antiviral compounds demonstrated efficacy against C. parvum.
- All six effective compounds were identified as nucleoside analogs.
- Five of the effective nucleoside analogs were structurally related.
Conclusions:
- Nucleoside analogs represent a promising class of compounds for developing new therapies against Cryptosporidium parvum.
- Further investigation and development of these nucleoside analogs could lead to effective treatments for cryptosporidiosis.
Related Concept Videos
01:28Antimicrobial Effectiveness
01:15Anthelminthic Agents